European Union:
COVID-19 Key EU Developments, Policy & Regulatory Update No. 17
29 October 2020
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
This regular update (no. 17 | 17 July 2020) covers key
regulatory EU developments related to the evolving COVID-19
situation (Antitrust & State Aid; Trade/Export Controls;
Medicines, Medical Devices and Personal Protective Equipment; and
Cybersecurity, Privacy & Data Protection).
Attachments
COVID-19 Key EU Developments No.
17.pdf
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Coronavirus (COVID-19) from European Union
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.